Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d33e45e5cbd64b8b893bd62ee22a85b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
2007-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6524d1ca6e94408bfe3bfe9d533cd097 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49cc566c7e3e0eec26cd45b83c0a4f19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da22c28585564fb325eb1430f1e339dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed777e9566f2189457683585ca44144a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebe43d4bf5542dbe44247ee8054ea216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f46d2bbff2340732208d107b2dadc3d |
publicationDate |
2013-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2007252986-B2 |
titleOfInvention |
Progastrin inhibitors in the treatment of colon cancer |
abstract |
The present invention relates to inhibitors of progastrin induced repression of ICAT for treating and/or preventing colorectal cancer, adenomatous polyposis or metastasis displaying progastrin-secreting cells and cells in which the beta-catenin/Tcf-4-mediated transcriptional pathway is constitutively active. |
priorityDate |
2006-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |